These limited associations were unexpected in light of recent work supporting associations between JAM-A expression and key clinicopathological factors in some cancers [6,7,12]; and they naturally suggest the advisability of broadening any limited methodological study into future work with greater patient numbers, a wider representation of ages or cancer subtypes, and a capacity to mechanistically investigate any observations made. Here, F11R is linked to cancer.